Nu Skin Enterprises, Inc. (NYSE:NUS) saw some unusual options trading on Thursday. Traders acquired 16,027 put options on the company. This is an increase of approximately 1,766% compared to the typical volume of 859 put options.

Shares of Nu Skin Enterprises (NUS) opened at 64.10 on Friday. The firm has a 50 day moving average price of $60.94 and a 200-day moving average price of $55.08. The company has a market cap of $3.39 billion, a price-to-earnings ratio of 21.27 and a beta of 1.32. Nu Skin Enterprises has a 12-month low of $46.35 and a 12-month high of $66.04.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Wednesday, May 3rd. The company reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.01. The business had revenue of $499.10 million for the quarter, compared to the consensus estimate of $493.65 million. Nu Skin Enterprises had a return on equity of 23.45% and a net margin of 7.48%. The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.42 earnings per share. On average, equities analysts expect that Nu Skin Enterprises will post $3.12 earnings per share for the current fiscal year.

A number of research firms recently weighed in on NUS. Pivotal Research reaffirmed a “buy” rating and set a $65.00 price objective on shares of Nu Skin Enterprises in a research report on Thursday, May 4th. Zacks Investment Research lowered Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. ValuEngine raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Sidoti lowered Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 target price for the company. in a report on Wednesday, April 26th. Finally, Bank of America Corporation lifted their target price on Nu Skin Enterprises from $53.00 to $57.00 and gave the stock an “underperform” rating in a report on Monday, July 10th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $62.25.

In related news, General Counsel D Matthew Dorny sold 8,000 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $56.39, for a total transaction of $451,120.00. Following the completion of the transaction, the general counsel now owns 52,730 shares of the company’s stock, valued at approximately $2,973,444.70. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In the last ninety days, insiders have sold 24,250 shares of company stock valued at $1,436,770. 5.20% of the stock is owned by corporate insiders.

Several institutional investors have recently added to or reduced their stakes in the stock. State Street Corp increased its position in Nu Skin Enterprises by 2.4% in the fourth quarter. State Street Corp now owns 802,056 shares of the company’s stock valued at $38,321,000 after buying an additional 18,471 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Nu Skin Enterprises by 4.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 947,226 shares of the company’s stock valued at $45,260,000 after buying an additional 39,926 shares during the last quarter. Renaissance Technologies LLC increased its position in Nu Skin Enterprises by 269.9% in the fourth quarter. Renaissance Technologies LLC now owns 200,100 shares of the company’s stock valued at $9,561,000 after buying an additional 146,000 shares during the last quarter. New York State Teachers Retirement System increased its position in Nu Skin Enterprises by 2.1% in the fourth quarter. New York State Teachers Retirement System now owns 4,900 shares of the company’s stock valued at $234,000 after buying an additional 100 shares during the last quarter. Finally, Guggenheim Capital LLC increased its position in Nu Skin Enterprises by 2.8% in the fourth quarter. Guggenheim Capital LLC now owns 74,693 shares of the company’s stock valued at $3,569,000 after buying an additional 2,020 shares during the last quarter. 85.51% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/07/23/nu-skin-enterprises-sees-unusually-high-options-volume-nus.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.